Navigation Links
ESHRE's first workshop on male infertility in Thessaloniki
Date:9/16/2009

ESHRE invites you to attend its first workshop on male infertility in Thessaloniki, Greece "Reproductive andrology: linking laboratory to clinical practice".

The workshop provides a forum for clinicians and scientists to share research results and discuss new developments.

Here some of the new research findings that fertility experts from in and outside of Europe will announce:

  • Nature versus Nurture: Male reproductive disorders a gene-lifestyle-environment interaction?
  • Latest data on semen populations in Europe
  • WHO guidelines and reference values for male infertility
  • Treatment options for male infertility
  • Fertility preservation freezing sperm

Reproductive medicine is one of today's most exciting scientific and clinical areas. Every month brings announcements of research developments, medical 'firsts', new rulings by regulatory bodies, or ethical controversies often sparking a heated debate among practitioners in the field themselves, as well as ethicists, legislators, the media and the public.

ESHRE's activities provide the media with the opportunity to hear the latest research news and interview the experts. All sessions are open to the media.

ESHRE is pleased to offer access to this workshop to bona fide journalists in possession of a recognized press card or a commissioning letter on headed paper from the publication they are working for. Registration is free of charge. Journalists are required to observe embargoes as indicated either by ESHRE staff or by the date/time of the presented session.


'/>"/>

Contact: Hanna Hanssen
hanna@eshre.com
322-269-0969
European Society for Human Reproduction and Embryology
Source:Eurekalert

Page: 1

Related biology news :

1. Secrets in a seed: Clues into the evolution of the first flowers
2. Scientists use microRNAs to track evolutionary history for first time
3. Researchers find first evidence of virus in malignant prostate cells
4. The first DNA barcodes of commonly traded bushmeat are published
5. World-first swine-flu vaccine trial reveals one dose provides strong immune response
6. NASA researcher nets first measure of Africas coastal forests
7. The first gene-encoded amphibian toxin isolated
8. First human gene implicated in regulating length of human sleep
9. Britains first swine-flu trials under way
10. Launch of the first standard graphical notation for biology
11. First human gets new antibody aimed at hepatitis C virus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)...  The Office of Justice Programs, National Institute ... Enhance or Replace Medico Legal Autopsies?" on NIJ.gov.  ... replacing forensic autopsies with postmortem X-ray computed tomography, ... response to recommendations made by The National Academy ... as a potential component of medicolegal death investigations. ...
(Date:11/30/2016)... 30, 2016 Not many of us realize that we spend ? of ... we need to do it well. Inadequate sleep levels have been found to lead ... diabetes, and even cancer. Maybe now is the best time to rethink ... them to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... 29, 2016   Neurotechnology , a ... recognition technologies, today released FingerCell 3.0, a ... solutions that run on low-power, low-memory microcontrollers. ... less than 128KB of memory, enabling it ... have limited on-board resources, such as: mobile ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... , ... December 08, 2016 , ... This CAST literature ... for biotech crops. The authors focus on the economic effects in countries that are ... of new biotech crops and the resultant risk of low level presence (LLP) puts ...
(Date:12/8/2016)... HOWELL, N.J. , Dec. 8, 2016 /PRNewswire/ ... aquatic augmentation remediation technologies and selected NewTechBio,s NT-MAX ... , a microbial based beneficial bacteria, in conjunction ... Inc., to correct deficiencies with National Pollutant Discharge ... basin 281-8H has experienced a steady history of ...
(Date:12/7/2016)... Diego (PRWEB) , ... December 07, 2016 , ... ... data from its phase I/II dose escalation and expansion clinical trial for its ... in Vienna, Austria. The purpose of the trial was to determine the safety, ...
(Date:12/7/2016)... , Dec. 7, 2016 /PRNewswire/ - OncoQuest ... development and commercialization of immunotherapeutic products for the ... entered into an Antibody Manufacturing Development Program with ... , USA) for its oregovomab antibody product. Supported ... Phase IIb clinical study in ovarian cancer patients, ...
Breaking Biology Technology: